Associated Papers
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
Mittal K et al.
Communications Biology, 2024
38589567 (PubMed )
Supplement: 42003_2024_6140_MOESM1_ESM.pdf
Essential role of the amino-terminal region of Drosha for the Microprocessor function.
Prabhakar A et al.
Iscience, 2023
Molecular Biomarkers and Drug Targets in Brain Arteriovenous and Cavernous Malformations: Where Are We?
Venugopal V et al.
Stroke, 2022
Non-Coding RNAs and Hereditary Hemorrhagic Telangiectasia.
Cannavicci A et al.
Journal of Clinical Medicine, 2020
Differential Expression of Circulating Plasma miRNA-370 and miRNA-10a from Patients with Hereditary Hemorrhagic Telangiectasia.
Ruiz-Llorente L et al.
Journal of Clinical Medicine, 2020
Recent Advances in Basic Research for Brain Arteriovenous Malformation.
Barbosa Do Prado L et al.
International Journal of Molecular Sciences, 2019
Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia.
Hata A et al.
Current Opinion in Hematology, 2019
Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia.
Jiang X et al.
Science Signaling, 2018
Select a paper to view details